Navigation Links
Arcturus Therapeutics Announces Collaboration with Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH)
Date:12/6/2016

SAN DIEGO, Dec. 6, 2016 /PRNewswire/ -- Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), a leading RNA medicines company, announced today that it entered into collaboration with Takeda Pharmaceutical Company Limited, to develop RNA-based therapeutics for the treatment of NASH and other gastrointestinal (GI) related disorders, utilizing Arcturus' wholly-owned therapeutic delivery platform LUNAR™ and UNA Oligomer chemistry. The financial terms were not disclosed.

"Given Takeda's long-standing commitment to and expertise in GI disorders, we are confident we have found an ideal partner to accelerate and maximize the potential of our LUNAR and UNA technology platforms toward the development of novel RNA therapeutics for the treatment of NASH," said Dr. Pad Chivukula, CSO & COO of Arcturus Therapeutics, Inc. "This agreement underscores Arcturus' ability to rapidly discover, design and optimize RNA medicines in areas of unmet need." 

About Arcturus Therapeutics, Inc.   

Founded in 2013 and based in San Diego, Arcturus Therapeutics, Inc. is an RNA medicines company with enabling technologies — UNA Oligomer chemistry and LUNAR™ nanoparticle delivery. Arcturus' versatile RNA therapeutics platform can be applied toward all types of RNA medicines including small interfering RNA, messenger RNA, antisense RNA, microRNA and gene editing therapeutics. The company owns LUNAR™ nanoparticle delivery and unlocked nucleomonomer agent (UNA) technology including UNA Oligomers™, which are covered by its patent portfolio (77 patents and patent applications, issued in the U.S., Europe, Japan and other countries). Arcturus' proprietary UNA technology can be used to target any gene in the human genome, as well as viral genes, and other species for therapeutic purposes. The Company's commitment to the development of novel RNA therapeutics has led to collaborations and license agreements with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, and Ultragenyx Pharmaceutical, Inc. For more information, visit www.ArcturusRx.com.

Logo - http://photos.prnewswire.com/prnh/20130531/MM24393LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arcturus-therapeutics-announces-collaboration-with-takeda-pharmaceuticals-to-develop-rna-based-therapeutics-for-the-treatment-of-nonalcoholic-steatohepatitis-nash-300373830.html


'/>"/>
SOURCE Arcturus Therapeutics
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Arcturus Therapeutics Receives Intent to Grant Notice from the European Patent Office for their Unlocked Nucleomonomer Agent (UNA) Technology
2. Arcturus Therapeutics Announces the Appointment of Drew Weissman M.D., Ph.D. to the Scientific Advisory Board
3. Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines for Defined Indications
4. Arcturus Therapeutics to Present at the Genetic Rx Boston Biotech Conference
5. Arcturus Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference
6. Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program
7. Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech
8. Viking Therapeutics Receives Orphan Drug Designation for VK0214 from the U.S. Food and Drug Administration for the Treatment of X-Linked Adrenoleukodystrophy
9. Mission Therapeutics Appoints Colin Goddard as Chairman
10. Research Reports Initiation on Healthcare Stocks -- NuVasive, Smith & Nephew, Nxstage Medical, and Cesca Therapeutics
11. Research Reports Coverage on Biotech Stocks -- Celldex Therapeutics, Amicus Therapeutics, Navidea Biopharma, and Concordia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2019)... (PRWEB) , ... July 10, 2019 , ... ... with life-saving medical equipment to the Zoe Geh Hospital located in rural Liberia, ... a unique program that enables students in the biomedical engineering technology courses at ...
(Date:7/10/2019)... ... 2019 , ... Successful actor and philanthropist, Laurence Fishburne, is ... of healthcare and how these costs affect American consumers. , The episode addresses ... painful decisions families face between paying for essential health services they require and ...
(Date:7/9/2019)... ... , ... State-of-the-art aesthetic and wellness provider, COR Medspa, offers leading vein treatments ... Laser vein treatment utilizes non-invasive laser energy to remove unsightly spider ... Sclerotherapy is a trusted vein treatment that injects varicose or spider veins ...
Breaking Medicine Technology:
(Date:7/10/2019)... ... July 10, 2019 , ... Given that fertility treatment ... (SGF) remains committed to its core mission of fertility education and spreading ... the practice will host six in-person seminars and three virtual webinars on topics ...
(Date:7/9/2019)... ... , ... Human cytomegalovirus (HCMV) may not be a household name as far ... at UMD, half of the population walking around campus is likely to be a ... life and can flare up whenever your immune system is severely compromised, giving you ...
(Date:7/9/2019)... ... July 09, 2019 , ... MM&M today debuted ... communications. Covering everything from multinational holding companies to five-person creative boutiques, the Agency ... version of the Agency 100 contains a full profile for Benchworks , ...
(Date:7/9/2019)... WASHINGTON (PRWEB) , ... July 09, 2019 , ... ... managing obstetrics, announced today that they are teaming up with Atrium Health, one ... The collaboration provides pregnant patients who receive care at Atrium Health access to ...
(Date:7/9/2019)... ... July 09, 2019 , ... ... the journey to spiritual growth at a recent Trivedi Effect® workshop. During the ... journey. , “It is difficult to explain truth,” said Dahryn Trivedi, as she ...
Breaking Medicine News(10 mins):